Biopharmaceutical – Biasly

Biopharmaceutical Follow

default thumbnail

Denosumab

Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints

Financial Post
Apr 08, 2024

Center

Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer -- Here Are 2 Stocks to Take Advantage

Non-alcoholic fatty liver disease

Obesity Drugs Have Multi-Billion-Dollar Market Potential, Says Oppenheimer -- Here Are 2 Stocks to Take Advantage

Yahoo Finance
Dec 04, 2023

Somewhat Liberal

UFOs: Former Intelligence Official Testifies

United Australia Party

UFOs: Former Intelligence Official Testifies"Non-Human Biologics" Found at Crash Sites

Comicbook
Jul 27, 2023

Center

Fear of 'aliens' on the rise as David Grusch testifies 'non-human' biologics and pilots at UFO hearing

Unidentified flying object

Fear of 'aliens' on the rise as David Grusch testifies 'non-human' biologics and pilots at UFO hearing

HITC
Jul 27, 2023

Somewhat Liberal

UFO whistleblower claims US government found 'non-human biologics' at crash sites

Unidentified flying object

UFO whistleblower claims US government found 'non-human biologics' at crash sites

SkyNews
Jul 27, 2023

Center

Vivek Ramaswamy raises $7.7M in second quarter of 2024

Milwaukee

Vivek Ramaswamy raises $7.7M in second quarter of 2024

New York Post
Jul 15, 2023

Center

Pfizer Eyes Seagen Takeover For More Than $30bn; Full List Of Pandemic-Driven Acquisition Spree

Market capitalization

Pfizer Eyes Seagen Takeover For More Than $30bn; Full List Of Pandemic-Driven Acquisition Spree

International Business Times
Feb 27, 2023

Somewhat Conservative

Six of the Top 20 Pharma Select Veeva Vault EDC as Company Standard for New Trials

Data processing

Six of the Top 20 Pharma Select Veeva Vault EDC as Company Standard for New Trials

Yahoo News
Feb 23, 2023

Somewhat Liberal

The Global Clinical Trial Support Services Market is expected to grow by $8.37 bn during 2022-2026, accelerating at a CAGR of 7.4% during the forecast period

Clinical trial

The Global Clinical Trial Support Services Market is expected to grow by $8.37 bn during 2022-2026, accelerating at a CAGR of 7.4% during the forec...

Yahoo News
Oct 05, 2022

Center

The Global Clinical Trial Support Services Market is expected to grow by $8.37 bn during 2022-2026, accelerating at a CAGR of 7.4% during the forecast period

Clinical trial

The Global Clinical Trial Support Services Market is expected to grow by $8.37 bn during 2022-2026, accelerating at a CAGR of 7.4% during the forec...

Yahoo News
Oct 05, 2022

Center

Opinion | California Does Big Pharma

California

Opinion | California Does Big Pharma

WSJ
Jul 21, 2022

Center

America faces supply-chain disruption and shortages. Here's why | Matt Stoller

Car

America faces supply-chain disruption and shortages. Here's why | Matt Stoller

The Guardian
Oct 01, 2021

Center